The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment

Abstract

The diversity and composition of the upper-airway microbiome are associated with asthma exacerbations despite ICS treatment. The salivary microbiome has a potential application as a biomarker of asthma exacerbations despite receipt of ICS.